May 08, 2024 / 08:30PM GMT
Operator
Hello, and welcome to the Mirum Pharmaceuticals first quarter 2024 financial results and business update. My name is Terry, and I'll be the conference operator today. (Operator Instructions)
I will now hand the call over to Andrew McKibben, Vice President of Investor Relations, to begin. Please go ahead.
Andrew Mckibben - Mirum Pharmaceuticals Inc - IR Contact Officer
Thanks, Terry, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals first quarter 2024 conference call.
I'm joined today by our CEO, Chris Peetz; our President and Chief Operating Officer, Peter Radovich; our Chief Medical Officer, Joanne Quan; and Eric Bjerkholt, our Chief Financial Officer. Earlier today, Mirum issued a news release announcing the company's results for the first quarter of 2024. Copies of this news release and SEC filings can be found in the Investors section of our website.
Before we begin, I'd like to remind you that during the course of this conference call, we will be making certain forward-looking statements about Mirum
Q1 2024 Mirum Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot